Neglected bacterial zoonoses

Clinical Microbiology and Infection

Volumn 21, Issue 5, 2015, Pages 404-415

  Chikeka, I ^a   Dumler, J S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Acute febrile illness; Borrelia; Chiggers; Fleas; Leptospira; Orientia; Relapsing fever; Rickettsia; Ticks; Vector borne bacteria

Indexed keywords

BACTERIAL INFECTION; BITE; BORRELIA INFECTION; CLINICAL FEATURE; DISEASE TRANSMISSION; FATALITY; FEVER; HUMAN; INTOXICATION; LEPTOSPIROSIS; MALARIA; MALARIA CONTROL; MORBIDITY; NONHUMAN; PARASITE VECTOR; PREVALENCE; PRIORITY JOURNAL; REVIEW; RICKETTSIOSIS; SCRUB TYPHUS; THREAT; TYPHUS; ZOONOSIS; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CLASSIFICATION; COMMUNICABLE DISEASE CONTROL; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEGLECTED DISEASES; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PROCEDURES; TRANSMISSION; VETERINARY; ZOONOSES;

ANIMALIA; ARTHROPODA; BACTERIA (MICROORGANISMS); BORRELIA; DENGUE VIRUS; IXODIDA; LEPTOSPIRA; MURINAE; ORIENTIA; RICKETTSIA; SIPHONAPTERA (FLEAS);

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INCIDENCE; NEGLECTED DISEASES; PREVALENCE; ZOONOSES;

EID: 84930539600     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.04.022     Document Type: Review

References (97)

1. Utzinger J., Becker S.L., Knopp S., et al. Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly 2012, 142:w13727.
2. Centers for Disease Control Summary of notifiable diseases-United States, 2012. Morbid Mortal Wkly Rep 2014, 61:1-121.
3. World Health Organization Neglected tropical diseases 2014, http://www.who.int/neglected_diseases/diseases/en/.
4. Centers for Disease Control Neglected tropical diseases 2014, http://www.cdc.gov/globalhealth/ntd/diseases/index.html.
5. Bill & Melinda Gates Foundation Neglected infectious diseases 2014, Bill & Melinda Gates Foundation, Seattle, WA. http://www.gatesfoundation.org/What-We-Do/Global-Health/Neglected-Infectious-Diseases#bodyregion_0_interiorarticle_0_strategysections_2_strategysubsections45615201ec9a4a6f8b6ec35aec7d7911_3_lnkHeader.
6. European Commission Neglected infectious diseases neglected no more 2014, http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/pdf/nid-leaflet_en.pdf.
7. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012, 380:2095-2128.
8. Joshi R., Kengne A.P., Neal B. Methodological trends in studies based on verbal autopsies before and after published guidelines. Bull World Health Organ 2009, 87:678-682.
9. Grosse S.D., Lollar D.J., Campbell V.A., Chamie M. Disability and disability-adjusted life years: not the same. Pub Health Rpt 2009, 124:197-202.
10. Paris D.H., Shelite T.R., Day N.P., Walker D.H. Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease. Am J Trop Med Hyg 2013, 89:301-307.
11. Acestor N., Cooksey R., Newton P.N., et al. Mapping the aetiology of non-malarial febrile illness in southeast asia through a systematic review-terra incognita impairing treatment policies. PLoS ONE 2012, 7:e44269.
12. Mayxay M., Castonguay-Vanier J., Chansamouth V., et al. Causes of non-malarial fever in laos: a prospective study. Lancet Glob Health 2013, 1:e46-e54.
13. Reller M.E., Bodinayake C., Nagahawatte A., et al. Unsuspected rickettsioses among patients with acute febrile illness, Sri Lanka, 2007. Emerg Infect Dis 2012, 18:825-829.
14. Reller M.E., Bodinayake C., Nagahawatte A., et al. Leptospirosis as frequent cause of acute febrile illness in southern Sri Lanka. Emerg Infect Dis 2011, 17:1678-1684.
15. Murdoch D.R., Woods C.W., Zimmerman M.D., et al. The etiology of febrile illness in adults presenting to patan hospital in Kathmandu. Nepal Am J Trop Med Hyg 2004, 70:670-675.
16. Chheng K., Carter M.J., Emary K., et al. Aprospective study of the causes of febrile illness requiring hospitalization in children in Cambodia. PLoS ONE 2013, 8:e60634.
17. Punjabi N.H., Taylor W.R., Murphy G.S., et al. Etiology of acute, non-malaria, febrile illnesses in Jayapura, northeastern Papua, Indonesia. Am J Trop Med Hyg 2012, 86:46-51.
18. Bharti A.R., Nally J.E., Ricaldi J.N., et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757-771.
19. Levett P.N. Leptospirosis. Clin Microbiol Rev 2001, 14:296-326.
20. Hartskeerl R.A., Collares-Pereira M., Ellis W.A. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 2011, 17:494-501.
21. Ko A.I., Goarant C., Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 2009, 7:736-747.
22. Brenner D.J., Kaufmann A.F., Sulzer K.R., Steigerwalt A.G., Rogers F.C., Weyant R.S. Further determination of DNA relatedness between serogroups and serovars in the family leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. Int J Syst Bacteriol 1999, 49(Pt 2):839-858.
23. Schreier S., Doungchawee G., Chadsuthi S., Triampo D., Triampo W. Leptospirosis: Current situation and trends of specific laboratory tests. Expert Rev Clin Immunol 2013, 9:263-280.
24. Katz A.R., Ansdell V.E., Effler P.V., Middleton C.R., Sasaki D.M. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001, 33:1834-1841.
25. Pappas G., Papadimitriou P., Siozopoulou V., Christou L., Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis 2008, 12:351-357.
26. Organization WH Leptospirosis burden epidemiology reference group (lerg) 2015, http://www.who.int/zoonoses/diseases/lerg/en/index2.html.
27. Rafizah A.A., Aziah B.D., Azwany Y.N., et al. Ahospital-based study on seroprevalence of leptospirosis among febrile cases in northeastern Malaysia. Int J Infect Dis 2013, 17:e394-e397.
28. Lindo J., Brown P.D., Vickers I., Brown M., Jackson S.T., Lewis-Fuller E. Leptospirosis and malaria as causes of febrile illness during a dengue epidemic in Jamaica. Pathog Glob Health 2013, 107:329-334.
29. Reller M.E., Wunder E.A., Miles J.J., et al. Unsuspected leptospirosis is a cause of acute febrile illness in Nicaragua. PLoS Negl Trop Dis 2014, 8:e2941.
30. Reller M.E., Bodinayake C., Nagahawatte A., et al. Unsuspected dengue and acute febrile illness in rural and semi-urban southern Sri Lanka. Emerg Infect Dis 2012, 18:256-263.
31. Reller M.E., Akoroda U., Nagahawatte A., et al. Chikungunya as a cause of acute febrile illness in southern Sri Lanka. PLoS ONE 2013, 8:e82259.
32. Rafizah A.A., Aziah B.D., Azwany Y.N., et al. Leptospirosis in northeastern Malaysia: misdiagnosed or coinfection?. Int J Collab Res Intern Med Public Health 2012, 4:1419-1427.
33. Suputtamongkol Y., Niwattayakul K., Suttinont C., et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004, 39:1417-1424.
34. Traxler R.M., Callinan L.S., Holman R.C., Steiner C., Guerra M.A. Leptospirosis-associated hospitalizations, United States, 1998-2009. Emerg Infect Dis 2014, 20:1273-1279.
35. Souza V.M., Arsky Mde L., Castro A.P., Araujo W.N. Years of potential life lost and hospitalization costs associated with leptospirosis in Brazil. Revista de saude publica 2011, 45:1001-1008.
36. Adler B., Lo M., Seemann T., Murray G.L. Pathogenesis of leptospirosis: the influence of genomics. Vet Microbiol 2011, 153:73-81.
37. Verma A., Stevenson B. Leptospiral uveitis-there is more to it than meets the eye!. Zoonoses Public Health 2012, 59(Suppl.2):132-141.
38. Bajani M.D., Ashford D.A., Bragg S.L., et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. JClin Microbiol 2003, 41:803-809.
39. Brett-Major D.M., Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012, 2:CD008264.
40. Samarakoon Y.M., Gunawardena N. Knowledge and self-reported practices regarding leptospirosis among adolescent school children in a highly endemic rural area in sri lanka. Rural Remote Health 2013, 13:2360.
41. Sehgal S.C., Sugunan A.P., Murhekar M.V., Sharma S., Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 2000, 13:249-255.
42. Bracho G., Varela E., Fernandez R., et al. Large-scale application of highly-diluted bacteria for leptospirosis epidemic control. Homeopathy 2010, 99:156-166.
43. Barbour A.G., Hayes S.F. Biology of Borrelia species. Microbiol Rev 1986, 50:381-400.
44. Cutler S.J. Relapsing fever-a forgotten disease revealed. JAppl Microbiol 2010, 108:1115-1122.
45. Vial L., Diatta G., Tall A., et al. Incidence of tick-borne relapsing fever in West Africa: longitudinal study. Lancet 2006, 368:37-43.
46. Lescot M., Audic S., Robert C., et al. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 2008, 4:e1000185.
47. Houhamdi L., Raoult D. Excretion of living Borrelia recurrentis in feces of infected human body lice. JInfect Dis 2005, 191:1898-1906.
48. Larsson C., Andersson M., Bergstrom S. Current issues in relapsing fever. Curr Op Infect Dis 2009, 22:443-449.
49. Dworkin M.S., Schwan T.G., Anderson D.E., Borchardt S.M. Tick-borne relapsing fever. Infect Dis Clin North Am 2008, 22. 449-68, viii.
50. Mayegga E., Ljøstad U., Mygland Å., Monstad P. Absence of focal neurological involvement in tick-borne relapsing fever in northern Tanzania. Eur J Neurol 2005, 12:449-452.
51. Nordstrand A., Bunikis I., Larsson C., et al. Tickborne relapsing fever diagnosis obscured by malaria, Togo. Emerg Infect Dis 2007, 13:117-123.
52. Reller M.E., Chen W.H., Dalton J., Lichay M.A., Dumler J.S. Multiplex 5' nuclease quantitative real-time pcr for clinical diagnosis of malaria and species-level identification and epidemiologic evaluation of malaria-causing parasites, including Plasmodium knowlesi. JClin Microbiol 2013, 51:2931-2938.
53. McConnell J. Tick-borne relapsing fever under-reported. Lancet Infect Dis 2003, 3:604.
54. Barclay A.J., Coulter J.B. Tick-borne relapsing fever in central Tanzania. Trans R Soc Trop Med Hyg 1990, 84:852-856.
55. Yimer M., Mulu W., Ayalew W., Abera B. Louse-borne relapsing fever profile at Felegehiwot referral hospital, Bahir Dar City, Ethiopia: a retrospective study. BMC Res Notes 2014, 7:250.
56. Cutler S.J., Abdissa A., Trape J.F. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect 2009, 15:400-406.
57. Brouqui P., Stein A., Dupont H.T., et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore) 2005, 84:61-68.
58. Porcella S.F., Raffel S.J., Schrumpf M.E., Schriefer M.E., Dennis D.T., Schwan T.G. Serodiagnosis of louse-borne relapsing fever with glycerophosphodiester phosphodiesterase (Glpq) from Borrelia recurrentis. JClin Microbiol 2000, 38:3561-3571.
59. Seboxa T., Fekade D. Borrelia species (relapsing fever). Antimicrobial therapy and vaccines 2002, 117-120. Apple Trees Productions, LLC, New York. 2nd ed. V.L. Yu, R. Weber, D. Raoult (Eds.).
60. Blacksell S.D., Jenjaroen K., Phetsouvanh R., et al. Accuracy of rapid IgM-based immunochromatographic and immunoblot assays for diagnosis of acute scrub typhus and murine typhus infections in Laos. Am J Trop Med Hyg 2010, 83:365-369.
61. Dumler J.S., Barbet A.F., Bekker C.P., et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001, 51:2145-2165.
62. Gillespie J.J., Williams K., Shukla M., et al. Rickettsia phylogenomics: unwinding the intricacies of obligate intracellular life. PLoS ONE 2008, 3:e2018.
63. Dahlgren F.S., Moonesinghe R., McQuiston J.H. Short report: race and rickettsiae: a United States perspective. Am J Trop Med Hyg 2011, 85:1124-1125.
64. Openshaw J.J., Swerdlow D.L., Krebs J.W., et al. Rocky Mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 2010, 83:174-182.
65. Aung A.K., Spelman D.W., Murray R.J., Graves S. Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers. Am J Trop Med Hyg 2014, 91:451-460.
66. Zhang L., Shan A., Mathew B., et al. Rickettsial seroepidemiology among farm workers, Tianjin, People's Republic of China. Emerg Infect Dis 2008, 14:938-940.
67. Walker D.H., Paddock C.D., Dumler J.S. Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections. Med Clin North Am 2008, 92. 1345-61, x.
68. Kelly D.J., Fuerst P.A., Ching W.M., Richards A.L. Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi. Clin Infect Dis 2009, 48(Suppl.3):S203-S230.
69. Thiga J.W., Mutai B.K., Eyako W.K., et al. High seroprevalence of antibodies against spotted fever and scrub typhus bacteria in patients with febrile illness, Kenya. Emerg Infect Dis 2015, 21:688-691.
70. Balcells M.E., Rabagliati R., Garcia P., et al. Endemic scrub typhus-like illness, Chile. Emerg Infect Dis 2011, 17:1659-1663.
71. Phongmany S., Rolain J.M., Phetsouvanh R., et al. Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis 2006, 12:256-262.
72. Koh G.C., Maude R.J., Paris D.H., Newton P.N., Blacksell S.D. Diagnosis of scrub typhus. Am J Trop Med Hyg 2010, 82:368-370.
73. Paris D.H., Blacksell S.D., Stenos J., et al. Real-time multiplex pcr assay for detection and differentiation of rickettsiae and orientiae. Trans Royal Soc Trop Med Hyg 2008, 102:186-193.
74. Phetsouvanh R., Thojaikong T., Phoumin P., et al. Inter- and intra-operator variability in the reading of indirect immunofluorescence assays for the serological diagnosis of scrub typhus and murine typhus. Am J Trop Med Hyg 2013, 88:932-936.
75. Jang M.O., Jang H.C., Kim U.J., et al. Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis. Antimicrob Agents Chemother 2014, 58:1488-1493.
76. Jang M.O., Kim J.E., Kim U.J., et al. Differences in the clinical presentation and the frequency of complications between elderly and non-elderly scrub typhus patients. Arch Gerontol Geriatr 2014, 58:196-200.
77. Brown G.W., Robinson D.M., Huxsoll D.L., Ng T.S., Lim K.J. Scrub typhus: a common cause of illness in indigenous populations. Trans Royal Soc Trop Med Hyg 1976, 70:444-448.
78. Chanyasanha C., Kaeburong K., Chenchittikul M., Sujirarat D. Seroprevalence of scrub typhus infection in patients with pyrexia at some malaria clinics in three western provinces of Thailand. Asian Pac J Allergy Immunol 1998, 16:119-125.
79. Varghese G.M., Trowbridge P., Janardhanan J., et al. Clinical profile and improving mortality trend of scrub typhus in South India. Int J Infect Dis 2014, 23:39-43.
80. Griffith M., Peter J.V., Karthik G., et al. Profile of organ dysfunction and predictors of mortality in severe scrub typhus infection requiring intensive care admission. Indian J Crit Care Med 2014, 18:497-502.
81. Kawamura A., Tanaka H. Rickettsiosis in Japan. Jpn J Exp Med 1988, 58:169-184.
82. Yang L.P., Liang S.Y., Wang X.J., Li X.J., Wu Y.L., Ma W. Burden of disease measured by disability-adjusted life years and a disease forecasting time series model of scrub typhus in Laiwu, China. PLoS Negl Trop Dis 2015, 9:e3420.
83. Gillespie J.J., Ammerman N.C., Beier-Sexton M., Sobral B.S., Azad A.F. Louse- and flea-borne rickettsioses: Biological and genomic analyses. Vet Res 2009, 40:12.
84. Maude R.R., Maude R.J., Ghose A., et al. Serosurveillance of Orientia tsutsugamushi and Rickettsia typhi in Bangladesh. Am J Trop Med Hyg 2014, 91:580-583.
85. Vallee J., Thaojaikong T., Moore C.E., et al. Contrasting spatial distribution and risk factors for past infection with scrub typhus and murine typhus in Vientiane city, Lao PDR. PLoS Negl Trop Dis 2010, 4:e909.
86. Gikas A., Doukakis S., Pediaditis J., Kastanakis S., Psaroulaki A., Tselentis Y. Murine typhus in Greece: epidemiological, clinical, and therapeutic data from 83 cases. Trans Royal Soc Trop Med Hyg 2002, 96:250-253.
87. Silpapojakul K., Chayakul P., Krisanapan S., Silpapojakul K. Murine typhus in Thailand: clinical features, diagnosis and treatment. QJ Med 1993, 86:43-47.
88. Dumler J.S., Taylor J.P., Walker D.H. Clinical and laboratory features of murine typhus in South Texas, 1980 through 1987. JAMA 1991, 266:1365-1370.
89. Walker D.H., Ismail N. Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events. Nat Rev Microbiol 2008, 6:375-386.
90. Cazorla C., Socolovschi C., Jensenius M., Parola P. Tick-borne diseases: tick-borne spotted fever rickettsioses in Africa. Infect Dis Clin North Am 2008, 22. 531-44, ix-x.
91. Parola P., Paddock C.D., Socolovschi C., et al. Update on tick-borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev 2013, 26:657-702.
92. Ismail N., Walker D.H., Ghose P., Tang Y.W. Immune mediators of protective and pathogenic immune responses in patients with mild and fatal human monocytotropic ehrlichiosis. BMC Immunol 2012, 13:26.
93. Susilawati T.N., McBride W.J. Acute undifferentiated fever in Asia: a review of the literature. SE Asian J Trop Med Public Health 2014, 45:719-726.
94. Kirkland K.B., Wilkinson W.E., Sexton D.J. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995, 20:1118-1121.
95. Chapman A.S., Bakken J.S., Folk S.M., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006, 55:1-27.
96. Botelho-Nevers E., Rovery C., Richet H., Raoult D. Analysis of risk factors for malignant mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. JAntimicrob Chemother 2011, 66:1821-1830.
97. Hamaguchi S., Cuong N.C., Tra D.T., et al. Clinical and epidemiological characteristics of scrub typhus and murine typhus among hospitalized patients with acute undifferentiated fever in northern vietnam. Am J Trop Med Hyg 2015, 92:972-978.